Medical Sciences
| Open Access |
Vol. 2 No. 04 (2022): Volume02 Issue04
| DOI:
https://doi.org/10.37547/medical-fmspj-02-04-01
USE OF OLOPAN (OLOPATADIN 0.1%) IN ALLERGIC OPTHALMOPATHOLOGY
Egamberdiyeva Saida Mamadjanovna , Assistant, Department of ophthalmology, Tashkent Medical Academy, Tashkent, Uzbekistan Sarvarkhon Akmaljon ugli Yuldashov , Master Student, Department of ophthalmology Tashkent Medical Academy Tashkent, Uzbekistan Umidjon Akramjon ugli Obidjonov , Master Student, Department of ophthalmology, Tashkent Medical Academy, Tashkent, Uzbekistan Dilshodbek Komildjan ugli Tokhtabayev , Master Student, Department of ophthalmology Tashkent Medical Academy Tashkent, UzbekistanAbstract
A statistical summary of epidemiological studies conducted by the World Health Organization (WHO) over the past 10 years has noted a global increase in the incidence of allergic diseases [1,7]. According to an official statement from the World Allergy Organization (WAO), the number of total allergens has now tripled, particularly the incidence of allergic ophthalmopathologies has increased by 25% [2,4].
Immunopathogenetic basis of allergic eye diseases is the activation of histamine receptors (H) and degranulation of mast cells [5,9,12]. The main purpose of this article is to review and analyze the existing scientific literature on olopatadine hydrochloride (Olopan 0.1% eye drop ), which is a relatively new topical antiallergic drug in ophthalmological practice, as well as to evaluate the effectiveness of Olopan drug by means of clinical research.
According to the results of laboratory experimentations in rabbits, almost all conjunctival allergic symptoms (conjunctival hyperemia, tearing, swelling of the eyelids, redness and chemosis) caused by specific allergens (eg, histamine allergic mediator) were eliminated in a short time. [1,3,6,14]. In this type of animal research or animal experimentation, olopatadine hydrochloride solution has been shown to have both antihistamine and membrane cell stabilizer properties [8, 10,11].
Keywords
Allergic ophthalmopathology, mast cells, olopatadine hydrochloride
References
Friedlander MH Current ocular therapy / Ed. by FT Frannfelder , FH Roy, J. Randall. Philadelphia: WB. Saunders Comp., 2000. 323 p.
Bogacka E. Epidemiology of allergic eye diseases // Pol. Merkur . Lekarski . 2003. Vol. 14. № 84. R. 714-715.
Brockman HL, Momsen MM, Knudtston JR, et al.//Ocular Immunol . Inflamm . - 2003. - v.2. - P.247–268.
Johansson SGO, Haahtela T.// Allergy and immunology. - 2005. - N1. - C. 81–91.
Maychuk Yu.F. // Bulletin of ophthalmology. - 2000. - №5. - S.10–14.
Maychuk Yu.F. // Klin . oftalmol . - 2002. - №1. - S. 6–9.
Abelson MB, Pratt S., Mussoline JF, et al. Clin . Ther . - 2003. - v.25. - P.2070–2084.
Brockman HL, Momsen MM, Knudtston JR, et al.//Ocular Immunol . Inflamm . - 2003. - v.2. - P.247–268.
Cornea and external eye disease. Ed. T. Reinhard , F. Larkin. Springer . - 2006. - 229P.
Davas RG // Chemical Immunology and Allergy. Ed. Johannes Ring et al. Carger . - 2006. - P. 110–120.
Leonardi A.//Emerging drugs. - 2005. - v.10. - №3. - P.505–520.
Sharif NA, Xu SX, Miller ST, et al./ / J. Pharmacol . Exp. Ther . - 1996. - v.278. - P.1252–1261.
World Health Organization. Prevention of allergies and allergic asthma . WHO. Geneva. WHO / NMH / MNC / CRA / 03.2.2003.
Qumri Islamovna Narzikulova, Sarvarkhon Akmaljon Ugli Yuldashov, Saida Mamadjanovna Egamberdiyeva, Shokhidakhon Adkhamovna Makhkamova. (2021). Practical Importance Use Of Modern Probiotics In Complex Treatment Of Adenoviral Conjunctivitis. The American Journal of Medical Sciences and Pharmaceutical Research , 3 (01), 210-215. (ISSN - 2689-1026) Doi : https://doi.org/10.37547/TAJMSPR/Volume03Issue01-32
Article Statistics
Downloads
Copyright License
Copyright (c) 2022 Egamberdiyeva Saida Mamadjanovna , Sarvarkhon Akmaljon ugli Yuldashov, Umidjon Akramjon ugli Obidjonov, Dilshodbek Komildjan ugli Tokhtabayev
This work is licensed under a Creative Commons Attribution 4.0 International License.